ArticleLeukemia2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5
Abstract readLetter
In one paragraph
Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Diagnostic Evolution of Haematological Neoplasms: A Narrative Review of the Road to Two Genetically Focused Classification Systems Through a Resource-Limited Perspective.Diagnostics (Basel, Switzerland) · 2026Review
- Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy.American journal of hematology · 2026Article
- Integration of CD200, CD43 and ROR1 in Multiparameter Flow Cytometry (MFC) Routine Panels for the Differential Diagnosis of B-cell lymphoproliferative Disorders (B-LPDs).Mediterranean journal of hematology and infectious diseases · 2025Article
- Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
45 authors.
Michael GreverDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. michael.grever@osumc.edu.ORCID 0000-0002-1605-7875
Leslie AndritsosDivision of Hematology Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Mirela AnghelinaCenter for Biostatistics, The Ohio State University, Columbus, OH, USA.
Evgeny AronsLaboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA.
Versha BanerjiDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, and Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada.
Jacqueline BarrientosMount Sinai Medical Center Miami, Miami, FL, USA.
Seema A BhatDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
James BlachlyDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.ORCID 0000-0002-4275-5562
Alessandro BroccoliIRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico "Sant'Orsola-Malpighi", and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy.ORCID 0000-0001-5633-7313
Timothy CallDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Claire DeardenThe Royal Marsden NHS Foundation Trust, London, UK.
Sascha DietrichUniversity Hospital of Düsseldorf, Düsseldorf, Germany.
Monica ElseThe Institute of Cancer Research, London, UK.ORCID 0000-0001-8578-4796
Narendranath EpperlaDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.ORCID 0000-0002-8216-3457
Andrei FagarasanuUniversity of Alberta, Edmonton, AB, Canada.
Brunangelo FaliniInstitute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy.
Francesco ForconiCancer Sciences and Haematology Department, University of Southampton and Cancer Care, Haematology Department, Southampton NHS University Hospital Trust, Southampton, UK.ORCID 0000-0002-2211-1831
Alessandro GozzettiDepartment of Medicine, Surgery and Neurosciences, University of Siena Policlinico S Maria alle Scotte, Siena, Italy.ORCID 0000-0003-0769-6891
Paul HampelDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-1292-3024
David J HermelDivision of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA.ORCID 0000-0001-6342-6023
Sunil IyengarThe Royal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0003-4863-4160
James B JohnstonDepartment of Medicine, University of Manitoba, Winnipeg, MB, Canada.ORCID 0000-0001-6614-083X
Gunnar JuliussonLund University/Dept of Hematology, Skåne University Hospital, Lund, Sweden.ORCID 0000-0002-7911-7265
Robert J KreitmanLaboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA.
Francesco LauriaUniversity of Siena, Siena, Italy.
Gerard LozanskiDepartment of Pathology, The Ohio State University Medical Center, Columbus, OH, USA.
Christopher C OakesDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
Sameer A ParikhDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3221-7314
Jae ParkMemorial Sloan Kettering Cancer Center, New York City, NY, USA.ORCID 0000-0002-2903-5130
Graeme QuestPathology and Molecular Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, ON, Canada.
Kanti RaiZucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA.ORCID 0000-0002-5804-2823
Farhad RavandiDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-7621-377X
Tadeusz RobakDepartment of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.ORCID 0000-0002-3411-6357
Kerry A RogersDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
Alan SavenDivision of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA.
John F SeymourPeter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0003-2188-6835
Tamar TadmorHematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.ORCID 0000-0002-3435-8612
Martin S TallmanRobert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.
Constantine S TamAlfred Hospital and Monash University, Melbourne, VIC, Australia.
Enrico TiacciInstitute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy.ORCID 0000-0001-8055-0931
Xavier TroussardDepartment of Hematology, Centre Hospitalier Universitaire Cote de Nacre, Caen, France.ORCID 0000-0001-6863-9992
Bernhard WörmannThe Charité - Universitätsmedizin, Berlin, Germany.ORCID 0000-0003-2273-5502
Clive S ZentJames P. Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0001-6099-3313
Thorsten ZenzDept. of Medical Oncology & Haematology, Univerity Hospital and University of Zurich; The LOOP Zurich - Medical Research Center, Zurich, Switzerland.ORCID 0000-0001-7890-9845
Pier Luigi ZinzaniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico "Sant'Orsola-Malpighi", and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy.ORCID 0000-0002-2112-2651
Funding
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3MDevelopment of Recombinant Toxins to Treat Hematologic MalignanciesZIABC010301 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KREITMAN, ROBERT · 2009 to 2025
$21.7MNCI NIH HHS P30 CA016058
Abstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Hairy CellWorld Health OrganizationHumans
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.